{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:10:40Z","timestamp":1759464640843,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1053\/j.ajkd.2022.12.010","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T08:43:31Z","timestamp":1677573811000},"page":"504-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Glycosphingolipid Metabolism in ADPKD: Another Roadblock for Treatment"],"prefix":"10.1053","volume":"81","author":[{"given":"Cortney N.","family":"Steele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen L.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2022.12.010_bib1","article-title":"Glycosphingolipid metabolism and polycystic kidney disease","volume":"69","author":"Natoli","year":"2020","journal-title":"Cell\u00a0Signal"},{"issue":"9","key":"10.1053\/j.ajkd.2022.12.010_bib2","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0022-2275(20)41159-9","article-title":"Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk\/cpk) mouse","volume":"35","author":"Deshmukh","year":"1994","journal-title":"J\u00a0Lipid Res"},{"issue":"6","key":"10.1053\/j.ajkd.2022.12.010_bib3","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0022-2275(20)39163-X","article-title":"Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease","volume":"37","author":"Chatterjee","year":"1996","journal-title":"J\u00a0Lipid Res"},{"issue":"7","key":"10.1053\/j.ajkd.2022.12.010_bib4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm.2171","article-title":"Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models","volume":"16","author":"Natoli","year":"2010","journal-title":"Nat Med"},{"issue":"10","key":"10.1053\/j.ajkd.2022.12.010_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100538","article-title":"The STAGED-PKD 2-stage adaptive study with a patient enrichment strategy and treatment effect modeling for improved study design efficiency in patients with ADPKD","volume":"4","author":"Perrone","year":"2022","journal-title":"Kidney Med"},{"issue":"5","key":"10.1053\/j.ajkd.2022.12.010_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1053\/j.ajkd.2022.10.016","article-title":"Venglustat, a novel glucosylceramide synthase inhibitor, in patients at risk of rapidly progressing ADPKD: primary results of a double-blind, randomized, controlled, phase 2\/3 clinical trial","volume":"81","author":"Gansevoort","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2022.12.010_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cpdd.865","article-title":"Pharmacokinetics, pharmacodynamics, safety, and tolerability of oral venglustat in healthy volunteers","volume":"10","author":"Peterschmitt","year":"2021","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"9","key":"10.1053\/j.ajkd.2022.12.010_bib8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJMe1006925","article-title":"mTOR inhibitors in polycystic kidney disease","volume":"363","author":"Watnick","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2022.12.010_bib9","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/HYPERTENSIONAHA.119.14507","article-title":"Endothelial sphingolipid de novo synthesis controls blood pressure by regulating signal transduction and no via ceramide","volume":"75","author":"Cantalupo","year":"2020","journal-title":"Hypertension"},{"issue":"7","key":"10.1053\/j.ajkd.2022.12.010_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021817","article-title":"Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide","volume":"6","author":"Spijkers","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1053\/j.ajkd.2022.12.010_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molmed.2018.10.009","article-title":"Ceramides as novel disease biomarkers","volume":"25","author":"Kurz","year":"2019","journal-title":"Trends Mol Med"},{"issue":"6585","key":"10.1053\/j.ajkd.2022.12.010_bib12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/381800a0","article-title":"Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate","volume":"381","author":"Cuvillier","year":"1996","journal-title":"Nature"},{"key":"10.1053\/j.ajkd.2022.12.010_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109518","article-title":"Apoptosis and autophagy in polycystic kidney disease (PKD)","volume":"68","author":"Nowak","year":"2020","journal-title":"Cell Signal"},{"issue":"15","key":"10.1053\/j.ajkd.2022.12.010_bib14","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1093\/hmg\/dds172","article-title":"Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease","volume":"21","author":"Natoli","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"23","key":"10.1053\/j.ajkd.2022.12.010_bib15","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1016\/S0021-9258(19)43220-1","article-title":"Synthesis of galactosylceramide and glucosylceramide by mouse kidney preparations","volume":"248","author":"Costantino-Ceccarini","year":"1973","journal-title":"J\u00a0Biol Chem"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862300522X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862300522X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:46:53Z","timestamp":1759463213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263862300522X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S027263862300522X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.12.010","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Glycosphingolipid Metabolism in ADPKD: Another Roadblock for Treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.10.016","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}